Results 11 to 20 of about 12,661 (240)
A case of autoimmune enteropathy with CTLA4 haploinsufficiency [PDF]
Autoimmune enteropathy (AIE) is a rare disease, characterized by intractable diarrhea, villous atrophy of the small intestine, and the presence of circulating anti-enterocyte autoantibodies. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked
Haruka Miyazaki +17 more
doaj +4 more sources
Background The majority of patients with recurrent or metastasized head and neck squamous cell carcinoma (HNSCC) do not benefit from immune checkpoint blockade (ICB) while several patients experience severe and persistent immune-mediated side effects ...
Friederike Hoffmann +18 more
doaj +2 more sources
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is an immune checkpoint expressed in regulatory T (Treg) cells and activated T lymphocytes. Despite its potential as a treatment strategy for melanoma, CTLA-4 inhibition has limited efficacy.
Prasanna Kumar Vaddi +17 more
doaj +2 more sources
Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patients
Cancer is the leading cause of death in the geriatric dog population. Currently, the use of immune checkpoint inhibitors (ICIs) such as anti-CTLA4 antibodies has markedly improved the prognosis of several cancers in their advanced stages.
Jonathan Marable +10 more
doaj +2 more sources
Xiudong Guan,1,2,* Yangyang Wang,1,2,* Yueqian Sun,2,3 Chuanbao Zhang,1,2 Shunchang Ma,2,4 Dainan Zhang,1,2 Deling Li,1,2 Wang Jia1,2,4 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic ...
Guan X +7 more
doaj +2 more sources
IntroductionImmunotherapy by blocking immune checkpoints programmed death/ligand (PD1/PDL1) and cytotoxic T-lymphocyte-associated protein 4(CTLA4) has emerged as new therapeutic targets in cancer.
Aida Jlassi +14 more
doaj +2 more sources
Context-Restricted PD-(L)1 Checkpoint Agonism by CTLA4-Ig Therapies Inhibits T Cell Activity
Summary: T cell surface CTLA4 sequesters the costimulatory ligands CD80 and CD86 on antigen-presenting cells (APCs) to prevent autoimmunity. Therapeutic immunosuppression by recombinant CTLA4-immunoglobulin (Ig) fusion proteins, including abatacept, is ...
Ross A. Dickins, Maximilian M Garwood
exaly +3 more sources
Evaluation of the - 318C/T (RS5742909) CTLA4 gene polymorphism influence on kidney function after transplantation [PDF]
Introduction: The protein CTLA-4 (Cytotoxic T Lymphocyte Antigen-4) is a molecule that plays a significant role in maintaining immunological homeostasis.
Veljančić Nevena, Perović Vladimir
doaj +1 more source
Frequency of CD39+, LAG3+, and CTLA4+ Regulatory T Cells in Two Different Immunosuppressive Protocols in Renal Allograft Recipients (Sirolimus vs Mycophenolate mofetil): A Cohort Report [PDF]
Background: Impaired renal function is considered as a significant risk factor for cardiovascular events in chronic kidney disease patients. Several immunosuppressive drugs are used in these patients, which necessitates to minimize the drug-related side ...
Yaghoub Mollaei-Kandelous +7 more
doaj +1 more source
Upregulation of Cytotoxic T-Lymphocyte-Associated Protein 4 and Forkhead Box P3 Transcripts in Peripheral Blood of Patients with Bladder Cancer [PDF]
Background: Regulatory T cells (Tregs) play a key role in the progression of tumors. These cells express forkhead box P3 (FOXP3) and cytotoxic T-lymphocyte-associated protein 4 (CTLA4), which are the potential targets for cancer immunotherapy.
Ali Ariafar +7 more
doaj +1 more source

